The Alzheimer's Drug Discovery Foundation presents:

Feeding the Pipeline: Novel Drug Discovery for Alzheimer's disease
A pre-conference symposium to the 3rd Clinical Trials for Alzheimer's Disease (CTAD) conference
November 3, 2010  • Toulouse France

The purpose of this conference is to present exciting drug discovery efforts in the field of Alzheimer's disease that complement approaches in advanced clinical trials. Speakers will be predominantly from the European biotechnology sector. There will be ample opportunity for discussion and for scientists from academia, industry and funding organizations to network and exchange ideas.

TIME	TITLE	SPEAKER
8:30-8:40	Introduction and Opening Remarks	Howard Fillit, MD, ADDF Alzheimer's Drug Discovery Foundation (ADDF)
8:40-9:20	Plenary Talk
9:20-10:20	Selected presentations from abstract submissions
10:20-10:35	Break
10:35-12:05	Selected presentations from abstract submissions
12:05-1:30	LUNCH -- off site
1:30-2:30	Selected presentations from abstract submissions
2:30-2:50	Novel Funding Models for Drug Discovery	Andrea W. Tobias, PhD Aquila Consulting Group
2:50-3:00	Break
3:00-4:00	PANEL: Funding Climate for Biotechnology Companies Chair: Andrea W. Tobias, PhD, Aquila Consulting Group Venture Capital: Philippe Peltier, Auriga Partners (invited) Government: Florence Lustman, Inspector General of Finances for France & Director of the French Alzheimer's Plan (invited) Pharma: Speaker TBD Foundation: Howard Fillit, MD, Alzheimer's Drug Discovery Foundation (ADDF)
4:00-4:05	Closing Remarks	Howard Fillit, MD, ADDF

 

Meeting Organizers: Howard Fillit, MD Diana Shineman, PhD

Scientific Advisory Committee: Luc Buee, PhD Andrea Tobias, PhD Bruno Vellas, MD, PhD Manfred Windisch, PhD